Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System
The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best chemotherapy choices for their patients. The investigators will conduct focus groups with cancer patients who have received chemotherapy treatment at MSK in order to understand cancer patients' thoughts about IBM Watson Oncology.
Checked against the public recordLast updated Jun 25, 2020 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Interventions being studied
- Behavioral: Focus groups
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * MSKCC patient 18 years or older * Breast, lung, or colorectal cancer MSK patient as per EMR or clinician judgment having either: * Chemotherapeutic adjuvant or neoadjuvant treatment with the first chemo visit occurring within the past 8 months and primary treatment (i.e., surgery), occurring within the past 6 months)at MSK * OR chemotherapeutic treatment for metastatic disease with the first chemo visit occurring within the past 8 months at MSK * OR chemotherapeutic treatment through an on-going MSK clinical trial as per clinician * Residing in New York metro-area Exclusion Criteria: * Non-English speakers because we do not have the resources to conduct and translate the focus groups into other languages * Patients who are not or will not receive their cancer care at MSKCC. * Patient unwilling or unable to provide informed consent
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Memorial Sloan Kettering Cancer CenterNew York, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 25, 2020. Always confirm current availability with the study team.